Research finds juvenile myositis and lupus share an inflammatory pathway, but their pathophysiological differences may serve as diagnostic biomarkers in future studies.
A new potential biomarker raises concerns over the current standard for treating COVID-19 induced blood clots with high dose blood thinners.
People whose blood pressure is hard to control might have another condition that’s the real culprit. So why aren’t they being tested for primary aldosteronism?
Researchers have created an experimental device that, instead of inhibiting inflammatory proteins in COVID-19 patients, changes the phenotype of circulating white blood cells, helping wean two patients off ECMO.
Are the vaccine trials being rushed? Are they safe? Two Michigan Medicine researchers weigh in.